Drug Profile
Research programme: cell therapies - GC Cell
Alternative Names: Autoimmune disease therapy - GC Cell; Dendritic cell therapy - GC Cell; Regulatory T cell therapy - GC Cell; Stem cell therapy - GC CellLatest Information Update: 12 Sep 2019
Price :
$50
*
At a glance
- Originator Innocell Corporation
- Developer GC Cell
- Class Cell therapies; Stem cell therapies
- Mechanism of Action Cell replacements; Cytokine-induced killer cell replacements; T lymphocyte replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Autoimmune disorders; Cancer
Most Recent Events
- 01 Sep 2019 Green Cross Cell is now called GC Cell
- 28 Jul 2018 No recent reports of development identified for preclinical development in Autoimmune-disorders in South Korea (Parenteral)
- 28 Jul 2018 No recent reports of development identified for preclinical development in Cancer in South Korea (Parenteral)